Gynecologic Cancers

Latest News

Endometrial cancer
Arn Unpacks Dostarlimab Approval for Patients With dMMR Advanced Endometrial Cancer

March 16th 2023

Courtney R. Arn, APRN-CNP, discusses the recent approval of dostarlimab for patients with mismatch repair–deficient recurrent or advanced endometrial cancer.

Ovarian Cancer
Mirvetuximab Soravtansine Offers New Path Forward for Patients with Frα-Positive Platinum-Resistant Ovarian Cancer

March 13th 2023

Lenvatinib/Pembrolizumab Efficacy Data Holds Up in Updated KEYNOTE-146 Analysis for Advanced Endometrial Carcinoma
Lenvatinib/Pembrolizumab Efficacy Data Holds Up in Updated KEYNOTE-146 Analysis for Advanced Endometrial Carcinoma

February 20th 2023

FDA approves dostarlimab
FDA Grants Regular Approval to Dostarlimab for dMMR Endometrial Cancer

February 9th 2023

Solid Tumors
Neoadjuvant Pembrolizumab Elicits High Response Among dMMR/MSI-H Solid Tumors

January 31st 2023

Video Series
Video Interviews
Podcasts
Oncology Nursing News
Are Hearing Tests Necessary For Adult Cancer Survivors?
Bringing a New Approach to Symptom Management in Ovarian Cancer

More News

© 2023 MJH Life Sciences

All rights reserved.